The Psychedelic Studies Research Program (PSRP) at the University of Toronto Mississauga is dedicated to understanding the effects of microdosing. The researchers at PSRP are a team of experts with varied backgrounds in neuroscience, clinical psychology, creative thinking, psychotherapy, and more.
The PSRP aims to gain an understanding of the potential benefits and drawbacks of microdosing. We are currently conducting a clinical trial of microdosing using very low doses of psilocybin, the primary active component in psychedelic mushrooms. We are investigating the effects of psychedelic microdosing using the principles of open science.